s6y

QIAGEN N.V.

Ticker
QGEN
CIK
1015820
Industry
Biological Products, (No Diagnostic Substances)
Formerly
QIAGEN NV

Ownership 81

  1. SC 13G Major Shareholders
  2. SC 13G Major Shareholders
  3. SC 13G Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G/A Major Shareholders
  8. SC 13G/A Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13G/A Major Shareholders

All 81 ownership filings

Prospectus 65

  1. SC TO-C Written communication relating to an issuer or third party tender offer
  2. SC TO-C Written communication relating to an issuer or third party tender offer
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. SC TO-T/A Third party tender offer statement
  5. SC TO-T/A Third party tender offer statement
  6. SC TO-T/A Third party tender offer statement
  7. SC TO-T/A Third party tender offer statement
  8. SC TO-T/A Third party tender offer statement
  9. SC TO-T/A Third party tender offer statement
  10. SC TO-T/A Third party tender offer statement

All 65 prospectus filings

Other 367

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. SCHEDULE 13G/A
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. SC14D9C Written communication by the subject company relating to a third party tender offer
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. SCHEDULE 13G/A

All 367 other filings